Can a new targeted pill tame advanced cancers? a phase i trial seeks answers

NCT ID NCT06413953

Recruiting now Disease control Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This early-stage trial tests an experimental drug called TQB3107, taken as a tablet, in people with advanced malignant tumors. The goal is to find a safe dose and understand how the body processes the drug. TQB3107 is designed to block a specific target inside cancer cells, potentially stopping their growth and triggering cell death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an experimental targeted inhibitor called TQB3107, taken as a tablet
What this could lead to: If safe and effective, TQB3107 could offer a new treatment option for people with advanced cancers that have not responded to other therapies.
What could go wrong: This is an early Phase I trial focused on safety and dosing, not yet on effectiveness. The drug may cause side effects or fail to shrink tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED CANCERS

Contacts and locations

Locations

Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, Shanghai Municipality, 200032, China
Harbin Medical University Cancer Hospital
RECRUITING

Harbin, Heilongjiang, 150081, China
Hunan Cancer Hospital
RECRUITING

Changsha, Hunan, 410013, China
Shandong Medical And Pharmaceutical University Hospital
RECRUITING

Binzhou, Shandong, 256699, China
Sun Yat-sen University Cancer Cen
RECRUITING

Guangzhou, Guangdong, 510060, China
The Affiliated Hospital of Chengde Medical College
RECRUITING

Chengde, Hebei, 67000, China
The Affiliated Hospital of Southwest Medical University
RECRUITING

Luzhou, Sichuan, 646000, China
The Fifth Affiliated Hospital Sun Yat-sen University
RECRUITING

Zhuhai, Guangdong, 519000, China
The First Affiliated Hospital, Zhejiang University School of Medicine
WITHDRAWN

Hangzhou, Zhejiang, 310000, China
The First People's Hospital Of Changzhou
RECRUITING

Changzhou, Jiangsu, 213000, China
Tianjin Municipality Locations
RECRUITING

Tianjin, Tianjin Municipality, 300060, China
West China Hospital，Sichuan University
RECRUITING

Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.